OR WAIT null SECS
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The EMEA intends to fully implement its Product Information Management (PIM) approach, an initiative designed to improve information management, into the centralized procedure within 2 years, according to a statement of intent from the agency.
The EMEA intends to fully implement its Product Information Management (PIM) approach, an initiative designed to improve information management, into the centralized procedure within 2 years, according to a statement of intent from the agency.
PIM implementation is in a pilot phase where PIM submissions are only accepted subject to prior discussion with the EMEA. The agency's statement, however, has outlined four main milestones that will lead to full implementation of PIM.
PIM was first introduced by the EMEA in December 2005 to help improve the management and exchange of product information, as well as its quality and consistency. According to a Q&A published on the agency's website, the PIM approach will "allow better interoperability with other regulatory agency information systems". It will also "facilitate provision of product information to the public and healthcare professionals as the data will be of higher quality, and files easier to navigate".
Ultimately, the agency believes that PIM will lead to better quality information.